Last reviewed · How we verify
NCT06697262: TELEDOM
Impact of a Telemonitoring Device on the Occurever at Home in Children at Risk of Chemotherapy-Induced Neutropenia
NA trial testing Remote temperature monitoring device in Oncopediatrics in 30 participants. Not yet recruiting.
4 May 2028
Quick facts
| Lead sponsor | Centre Hospitalier Universitaire de la Réunion |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 30 |
| Start date | 1 May 2026 |
| Primary completion | 4 May 2028 |
| Estimated completion | 4 May 2028 |
Drugs / interventions tested
- Remote temperature monitoring device
- Home temperature monitoring by a nurse
Conditions studied
- Oncopediatrics — all drugs for Oncopediatrics →
- Febrile Neutropenia — all drugs for Febrile Neutropenia →
Sponsor
Centre Hospitalier Universitaire de la Réunion
Who can join
Adults 0 to 17, any sex, with Oncopediatrics or Febrile Neutropenia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to evaluate the feasibility of the study, measured by the acceptability rate of patients to be recruited in a study proposing temperature monitoring at home, by a remote monitoring device or by the visit of an IDE at home (in association with the usual educational sessions), to children at risk of febrile neutropenia, from families with psycho-social vulnerabilities. The main questions it aims to answer are: * Will participants adhere to the telemonitoring system? * Is the intervention feasible, in terms of the device's failure to record temperature data? * Will parents behave appropriately when using the device? * How satisfied will parents and caregivers be? * What will be the physical tolerance of the device? * On an exploratory basis, will the remote monitoring system be effective for months? Researchers will compare : * patients using the telemonitoring device for continuous temperature monitoring at home, in combination with education sessions on temperature monitoring and the device * with patient with temperature monitoring at home by a nurse, 2 times a day, in combination with education sessions on temperature monitoring (without the telemonitoring device at home)
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06697262
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Centre Hospitalier Universitaire de la Réunion trials
Trials by the same sponsor.
- NCT07444515 — Prospective AnalysiS of Self medIcation With phytOtherapy in Nephropatic Patients. · NA · not yet recruiting
- NCT07190560 — Against Chikungunya Virus and Neonatal Infection · NA · not yet recruiting
- NCT07365670 — Comparison of the Best Method for Measuring Anti-Xa Activity in Children Receiving Unfractionated Heparin in Cardiac Int · NA · not yet recruiting
- NCT06485310 — Interest of a TEteleconsultation of a Psychological Support Nurse on Psychological Distress in Patients With a Primary M · NA · not yet recruiting
- NCT06507917 — Concordance and Acceptability of Self-screening Versus Screening by a Healthcare Professional for HPV, a Risk Factor for · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06697262 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de la Réunion
- Last refreshed: 20 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06697262.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing